AlzeCure Initiates Clinical Trial With ACD856
- Friday, December 20, 2019, 7:03
- Finance
- Add a comment
STOCKHOLM, Dec. 20, 2019 /PRNewswire/ — AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with a focus on Alzheimer’s disease, announces that it has obtained the…
About the Author
adminasapcorp has written 42197 stories on this site.